Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas

Open access

Abstract

BACKGROUND: Enumeration of circulating tumor cells (CTCs) isolated from the peripheral blood of breast cancer patients holds promise as a clinically relevant, minimally invasive diagnostic test. However, CTC utility has been limited as a prognostic indicator of survival by the inability to stratify patients beyond general enumeration. In comparison, histological biopsy examinations remain the standard method for confirming malignancy and grading malignant cells, allowing for cancer identification and then assessing patient cohorts for prognostic and predictive value. Typically, CTC identification relies on immunofluorescent staining assessed as absent/present, which is somewhat subjective and limited in its ability to characterize these cells. In contrast, the physical features used in histological cytology comprise the gold standard method used to identify and preliminarily characterize the cancer cells. Here, we superimpose the methods, cytologically subtyping CTCs labeled with immunohistochemical fluorescence stains to improve their prognostic value in relation to survival. METHODS: In this single-blind prospective pilot study, we tracked 36 patients with late-stage breast cancer over 24 months to compare overall survival between simple CTC enumeration and subtyping mitotic CTCs. A power analysis (1-β = 0. 9, α = 0.05) determined that a pilot size of 30 patients was sufficient to stratify this patient cohort; 36 in total were enrolled. RESULTS: Our results confirmed that CTC number is a prognostic indicator of patient survival, with a hazard ratio 5.2, p = 0.005 (95 % CI 1.6-16.5). However, by simply subtyping the same population based on CTCs in cytological mitosis, the hazard ratio increased dramatically to 11.1, p < 0.001 (95 % CI 3.1-39.7). CONCLUSIONS: Our data suggest that (1) mitotic CTCs are relativity common in aggressive late-stage breast cancer, (2) mitotic CTCs may significantly correlate with shortened overall survival, and (3) larger and more defined patient cohort studies are clearly called for based on this initial pilot study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13058-016-0706-4

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Common cytology of circulating tumor cells (CTCs) in mitosis, isolated from patients with breast cancer. Representative images of a the “classical” CTC in interphase (the most commonly found morphology), b prophase CTC with condensing chromatin, c metaphase CTC with condensed chromatin lining up along the axis, d metaphase/anaphase where two chromatins are separating along the cell plate, e anaphase where two chromosome sets are moving to cell poles, f telophase showing two cell envelopes and a contractile ring at the center of the cell, g cytokinesis showing the contractile ring pinching the cell into two, and h late cytokinesis during which the nuclear envelopes are reformed, contractile ring almost complete and chromatin has expanded. Blue 4',6-diamidino-2-phenylindole-positive nuclei, green cytokeratin. Scale bar 15 μm
Fig. 1 Common cytology of circulating tumor cells (CTCs) in mitosis, isolated from patients with breast cancer. Representative images of a the “classical” CTC in interphase (the most commonly found morphology), b prophase CTC with condensing chromatin, c metaphase CTC with condensed chromatin lining up along the axis, d metaphase/anaphase where two chromatins are separating along the cell plate, e anaphase where two chromosome sets are moving to cell poles, f telophase showing two cell envelopes and a contractile ring at the center of the cell, g cytokinesis showing the contractile ring pinching the cell into two, and h late cytokinesis during which the nuclear envelopes are reformed, contractile ring almost complete and chromatin has expanded. Blue 4',6-diamidino-2-phenylindole-positive nuclei, green cytokeratin. Scale bar 15 μmCC BY · PubMed Central
Fig. 2 Kaplan-Meier estimates of probabilities of overall survival in the breast cancer patient populations, total circulating tumor cell (CTC) count versus mitotic CTC count (n = 36). a Kaplan-Meier estimates of probabilities of overall survival of patients with breast cancer with <5 CTCs per sample vs patients with ≥5 CTCs per sample. b Kaplan-Meier estimates of probabilities of overall survival of patients with breast cancer with 0 mitotic CTCs per sample vs patients with ≥1 mitotic CTCs per sample
Fig. 2 Kaplan-Meier estimates of probabilities of overall survival in the breast cancer patient populations, total circulating tumor cell (CTC) count versus mitotic CTC count (n = 36). a Kaplan-Meier estimates of probabilities of overall survival of patients with breast cancer with <5 CTCs per sample vs patients with ≥5 CTCs per sample. b Kaplan-Meier estimates of probabilities of overall survival of patients with breast cancer with 0 mitotic CTCs per sample vs patients with ≥1 mitotic CTCs per sampleCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 42

Metadata

Authors
Adams, D. L., Adams, D. K., Stefansson, S., Haudenschild, C., Martin, S. S., Charpentier, M., Chumsri, S., Cristofanilli, M., Tang, C.-M., & Alpaugh, R. K.
Affiliations
  • Rutgers, The State University of New Jersey (US)
  • George Washington University (US)
  • University of Maryland, Baltimore (US)
  • Northwestern University (US)
  • Creatv MicroTech (United States) (US)
  • Fox Chase Cancer Center (US)
Corresponding author
Adams, Daniel L.
Venue
Breast Cancer Research
Published
2016-05-04
Volume
18
Issue
1
Pages
44-44
ISSN
  • 1465-5411 (ISSN-L)
  • 1465-542X
OpenAlex
W2346756257
Cited by
40
References
33
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 9 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 1
FWCI
2.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Breast Cancer Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Maryland Technology Development Corporation (MTTCF award)
  • National Cancer Institute (grant R01-CA154624)
  • Susan G. Komen for the Cure (KG100240)
  • U.S. Department of Defense (BC100675)
  • Defense Advanced Research Projects Agency (W911NF-14-C-0098)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
circulating tumor cells, mitosis, breast cancer, prognostic factors, overall survival, patient stratification, late-stage breast cancer, minimally invasive diagnosis
MeSH terms
Adult, Aged, Breast Neoplasms, Female, Humans, Middle Aged, Mitosis, Neoplastic Cells, Circulating, Neoplasm Staging, Prognosis, Prospective Studies, Biomarkers, Tumor, Proportional Hazards Models, Disease Progression, Kaplan-Meier Estimate, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas. https://app.cochat.ai/papers/10.1186/s13058-016-0706-4
The paper
Adams, D. L., Adams, D. K., Stefansson, S., Haudenschild, C., Martin, S. S., Charpentier, M., Chumsri, S., Cristofanilli, M., Tang, C.-M., & Alpaugh, R. K. (2016). Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas. Breast Cancer Research. https://doi.org/10.1186/s13058-016-0706-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.